Actualités sur Enterprises

Suivre
Abonner Enterprises
Filtre
  • 22.01.2009 – 10:26

    Novozymes A/S

    Novozymes Reports Strong 2008 Results

    Bagsvaerd, Denmark (ots/PRNewswire) - Leading biotechnology company Novozymes reports 13% sales growth in 2008. Earnings were also very satisfactory. Growth outlook for 2009 of 8-13% in DKK in an uncertain market. Strong long-term trends lead to new, increased targets and higher investments to support higher future growth level. - 2008 sales up by 13% in local currencies (LCY), 10% in DKK, ending at DKK ...

  • 20.01.2009 – 17:26

    European Wind Energy Association (EWEA)

    Wind Energy Jobs to Double by 2020 - New EWEA Study

    Brussels (ots/PRNewswire) - The European wind energy sector has created 33 new jobs every day for the past five years, journalists attending the launch of a new report from the European Wind Energy Association (EWEA) heard today. According to the report, entitled, 'Wind at Work - wind energy and job creation in the EU', jobs in wind energy will more than double from 154,000 to 325,000 by 2020. In 2007, wind energy ...

  • 19.01.2009 – 18:51

    Roche Pharmaceuticals

    Seasonal Influenza Activity Increasing Across Europe - H3N2 Dominant Strain

    Basel, Switzerland (ots/PRNewswire) - - Tamiflu Remains Fully Effective Against 94 Percent of Circulating Influenza Viruses in Europe Latest surveillance data coming through the European Centre for Disease Prevention and Control (ECDC) from virologists and clinicians indicates that the influenza A(H3N2) virus is the predominant strain in Europe so far this ...

  • 19.01.2009 – 14:09

    Atmel Corporation

    Atmel Offers Free Microsoft Windows Embedded BSPs for AT91SAM9 Embedded MPUs

    Rousset, France (ots/PRNewswire) - - Extensive Support and In-depth Training from Atmel and Adeneo Embedded Atmel(R) Corporation (Nasdaq: ATML) announced today the availability of Microsoft(R) Windows(R) Embedded Board Support Packages (BSPs) for its AT91SAM9 ARM926EJ-S(TM)-based embedded MPUs. The Windows Embedded CE 5.0 BSP and the Windows Embedded CE 6.0 ...

  • 15.01.2009 – 14:14

    Atmel Corporation

    Atmel's XMEGA MCU Awarded Product of the Year by Electronic Products Magazine

    San Jose, California (ots/PRNewswire) - - XMEGA Garners Award for Innovative Advancement in the 8/16-bit MCU Market Atmel(R) Corporation (Nasdaq: ATML) today announced its industry leading XMEGA(TM) microcontroller was awarded the 2008 Product of the Year by Electronic Products' Magazine. Since its introduction in early 2008, there have been over 400 design ...

  • 15.01.2009 – 01:07

    Ortho Clinical Diagnostics a Johnson & Johnson company

    Two Next Generation Clinical Diagnostic Platforms Now Available in Europe

    High Wycombe, England (ots/PRNewswire) - - Ortho Clinical Diagnostics Introduces Flagship VITROS(R) 5600 Integrated System and High-Capacity VITROS(R) 3600 Immunodiagnostic System Ortho Clinical Diagnostics today announced commercial availability in Europe(*) for two new clinical laboratory systems, the flagship VITROS(R) 5600 Integrated System and the ...

  • 11.01.2009 – 20:38

    Volvo Cars

    Volvo Goes 'Live' at Detroit Auto Show

    Gothenburg, Sweden (ots/PRNewswire) - - Volvo will Broadcast and Webcast Live from the North American International Auto Show - January 11, 2009. - "We will create an historic one-hour live TV show to be broadcast throughout North America and simultaneously presented on the World Wide Web. Media from around the world will be able to watch presentations from the Volvo display in Detroit while asking questions ...

  • 09.01.2009 – 09:06

    European Environment Agency

    Killer Slugs and Other Aliens

    Prague (ots/PRNewswire) - - EEA Signals 2009: Eight Environmental Stories for Europe Translated versions of Signals 2009 are available here: http://reports.eea.europa.eu/corporate_document_2009_1/en (Logo: http://www.newscom.com/cgi-bin/prnh/20090109/333827 ) Is gardening one of your interests? If so and you live in central or northern Europe the 'killer slug' is probably one of your personal enemies. The slug, which attacks your herbs and ...

  • 08.01.2009 – 17:36

    Agendia B.V.

    Agendia Appoints New Chief Financial Officer

    Huntington Beach, California, and Amsterdam (ots/PRNewswire) -- Agendia, a world leader in molecular cancer diagnostics, today announced the appointment of Kurt Schmidt, CPA, MBA, as the company's new Chief Financial Officer. "Kurt is an exceptional addition to our team and an invaluable asset," said Bernhard Sixt, Ph.D., President and Chief Executive Officer. "With his extensive financial management experience ...

  • 16.12.2008 – 14:09

    Xeround, Inc.

    Xeround Launches Xeround Intelligent Data Grid Version 2.8

    Bellevue, Washington (ots/PRNewswire) - - New Release Supports More Architectures; Increases Manageability to Further Improve Total Cost of Ownership Xeround, Inc., a provider of real-time database virtualization software, today announced the launch of the Xeround Intelligent Data Grid(TM) version 2.8. Xeround's vision is to enable cloud computing infrastructures for its customers by delivering data ...

  • 14.12.2008 – 18:50

    The Finnish Breast Cancer Group

    Xeloda Shows Strong Promise in Early Breast Cancer

    San Antonio, Texas (ots/PRNewswire) - - FOR NON-US DOMESTIC and NON-UK journalists only - Early Data Indicate Chemotherapy Pill Xeloda, Already Proven in Advanced Breast Cancer, May Also Reduce Recurrence of Early Breast Cancer Data presented today indicate that adding Xeloda to standard chemotherapy allows women to live cancer-free for longer. Preliminary data presented at the CTRC-AACR San Antonio Breast ...

  • 12.12.2008 – 15:45

    Agendia

    Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer

    Huntington Beach, California and Amsterdam (ots/PRNewswire) -- Agendia, a world leader in molecular cancer diagnostics, today announced MammaPrint(R)'s ability to predict response to neoadjuvant chemotherapy in breast cancer. Dr. Laura van 't Veer, from the Netherlands Cancer Institute, presented the data at the 2008 San Antonio Breast Cancer ...

  • 10.12.2008 – 08:03

    Diagnoplex SA

    Diagnoplex Closes CHF10 Million ($8.3 Million) Series A Financing

    Lausanne, Switzerland (ots/PRNewswire) - Diagnoplex, a developer of molecular cancer diagnostics today announced the closing of a Series A financing raising CHF10 million ($8.3 million). The A-round was led by Novartis Venture Fund and NeoMed, with Initiative Capital Romandie acting as co-investor. The Novartis Venture Fund was also a seed investor in the company. BCCC Avocats acted as counsel to the investors and BMP ...